What does BLIS K12 stand for?
BLIS K12 stands for the “good” bacterial species Streptococcus salivarius K12.
Streptococcus salivarius K12 are probiotic streptococci (Streptococcus salivarius K12) which, thanks to their beneficial properties, help to build up a healthy oral flora, among other things. Studies have shown that the Streptococcus salivarius K12 strain produces certain molecules that have antibiotic effects. The bacteriocins that are separated out as a result displace other “harmful” microorganisms and help, for example, to protect against periodontosis, to build up a healthy oral flora and, last but not least, to proactively protect against germs that can be the cause of sore throats. Further information can be found here or under our TV & Science section.
The strains used as probiotics (Streptococcus salivarius K12) have been scientifically well researched and classified as harmless. They occur naturally in humans.
Description of active ingredients
Certainly you feel like many Europeans when they are confronted with the terms stroptococcus salivarius or the fact that a bacterium is said to have antibiotic effects in the oral cavity, among other things. You are skeptical at first!
Therefore, a short excursion into science now follows to suggest how the bacterium stroptococcus salivarius works.
First of all, a small leap back in time: In the 1980s, Prof. Dr. John Tagg from the University of Otago in New Zealand, at that time still a pioneer in this field, carried out his studies on the said bacterium. He quickly found out that children, who are significantly seldom sick, particularly often had the bacterium stroptococcus salivarius in the mouth area. This bacterium is a form of natural oral flora. The bacterium itself produces the protein molecule BLIS K12 (English: Bakteriocin Like Inhibitory Substances). Long-term studies on New Zealand children show that those with a sufficient number of K12 molecules in the mouth and throat area, among other things. have fewer sore throats and tooth decay (see category “tooth decay” and “sore throat”) or are generally less ill (at this point we refer to our “TV and science” category) From now on it was clear: K12 has antibiotic effects and should be present in the mouth and throat as often as possible.
Through the targeted isolation of K12, Prof. Dr. John Tagg true pioneering work. Further positive properties could be ascertained: The most valuable thing for adults is the fight against bad breath (see category “Bad breath”). Because the presence of BLIS K12 in the mouth and throat area strengthens the natural oral flora and prevents the spread of bad breath bacteria. BLIS K12 thus acts like a bar for “bad” bacteria, which are disproportionately high in the mouth and throat of people with bad breath, tooth decay and sore throats.
But where is the difference to the commercially available antibiotic?
Very simple: BLIS K12 only affects the bad bacteria. This has a supportive effect. A commercially available antibiotic, on the other hand, attacks the bad as well as the good bacteria in a highly effective manner. Conversely, less good bacteria means that there is less protection against bad bacteria. This is precisely where the outstanding potential of BLIS K12 in terms of health support becomes apparent.
The positive properties of BLIS K12 have now been processed in the various products to a high quality, so that they can fully support them. On the New Zealand, American or Irish market, BLIS K12 has long been well established and easily available.
Information: Of course, BLIS K12 does not replace any antibiotic that is used in diseases. BLIS K12 has a supportive effect. A doctor should always be consulted in the event of illness. Depending on the country and approval, BLIS K12 represents a food, dietary supplement or cosmetic.